входит в структуру портала

Merck Sharp & Dohme

Merck Sharp & Dohme (MSD) is a research-driven pharmaceutical company engaged in research, development, manufacture and marketing of a wide range of pharmaceutical products. The headquarters are in the United States.

  • Isentress® (raltegravir)
  • Stocrin (efavirenz)

HepC portfolio

  • Pegintron® (Peginterferon alfa-2b)
  • Victrelis™ (boceprevir)

Information about the drug products is obtained from public sources or from company representatives and is intended solely for informing community representatives about the options currently available or in development. This information can under no circumstances be intepreted as advertising. The mentioning of any drug products does not mean EECA CAB prioritizes those products or, on the contrary, does not recommend them.

Hepatitis C pipeline

  • Inhibitors of NS5A
    • MK-8742, once a day, phase I/II
  • Protease inhibitors
    • MK-5172, once a day, phase III

Search our site ...